Jove
Visualize
お問い合わせ

関連する概念動画

Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

647
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
647
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

828
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
828
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

1.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.0K
The Electron Transport Chain01:30

The Electron Transport Chain

17.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

1.4K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The sustainability of the Morita-Baylis-Hillman reaction.

Chemical Society reviews·2026
Same author

Synthesis of <i>N</i>‑Substituted Acenaphtho[1,2‑<i>b</i>]pyrroles and Dibenzo[<i>e,g</i>]indoles with Promising Antileukemic Activity from Morita-Baylis-Hillman Adducts.

ACS omega·2026
Same author

Chalcones as Multi-target Ligands for Alzheimer's Disease: A Review of Synthetic Strategies and Therapeutic Promise.

Mini reviews in medicinal chemistry·2026
Same author

Discovery of 6,7-dimethoxyquinazoline-hydrazide hybrids as dual inhibitors of acetylcholinesterase and β-secretase.

Biochimie·2026
Same author

In Silico, in vitro, and in vivo studies of a 2-substituted quinazolin-4(3H)-one in T-cell acute lymphoblastic leukemia.

Toxicology and applied pharmacology·2025
Same author

Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3<i>H</i>)‑ones as Potential Antileukemic Agents.

ACS omega·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Sep 10, 2025

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

7.9K

ザンチン酸化抑制における進歩:潜在的な生物活性合成化合物のレビュー

Giorgio Antoniolli1, Gabriel Rodrigues de Moraes2, Rafael Porreca Neves da Costa1

  • 1Institute of Chemistry, University of Campinas, Campinas, São Paulo, Brazil.

Archiv der Pharmazie
|August 21, 2025
PubMed
まとめ
この要約は機械生成です。

新種の合成キサンチン酸化酵素阻害剤の開発は,高尿血症と痛風の治療に不可欠です. これらの新しい化合物は,有効性,安全性,および追加の治療上の利点の可能性を高めています.

キーワード:
ハイパーウリケミア阻害剤分子ドッキング合成ジャンチン酸化酵素

さらに関連する動画

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
09:04

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

Published on: September 9, 2016

10.7K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.0K

関連する実験動画

Last Updated: Sep 10, 2025

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

7.9K
A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
09:04

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products

Published on: September 9, 2016

10.7K
Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides CHIPS

Published on: June 20, 2014

14.0K

科学分野:

  • 薬剤化学
  • 薬理学について
  • 薬物の発見

背景:

  • ハイパーウリケミアと痛風は,現在の治療の限界と副作用により,治療に重大な課題を伴います.
  • 新しい薬の開発は,毒性,生物学的利用可能性の低下,および薬物相互作用によって妨げられています.
  • 治療の有効性,選択性,安全性を高めるために,新しい合成キサンチン酸化酵素阻害剤の必要性が極めて高い.

研究 の 目的:

  • 合成キサンチン酸化酵素阻害剤の開発における最近の進歩を体系的に検討する.
  • 新しい化合物の構造的多様性と治療的可能性を強調する.
  • 尿路高血症と痛風の改善のための有望な薬候補を特定する.

主な方法:

  • 2020年から2025年の間に発表された新しいキサンチン酸化酵素阻害剤の体系的な文献検索を実施した.
  • 分子構造で組織化された化合物です.
  • 追加の薬理学的な活動と新興研究傾向を持つ化合物の分析が含まれています.

主要な成果:

  • 合成キサンチン酸化酵素阻害剤のための多様な分子構造を特定した.
  • 抗炎症性,抗酸化性,抗コレネステラス性,抗癌性を持つ化合物が強調されています.
  • より効果的で安全な治療法の開発の進捗を強調した.

結論:

  • 最近の進歩は,合成のキサンチン酸化酵素阻害剤の開発に大きな進展を示しています.
  • 新しい分子は痛風と尿路高血症の治療結果を改善し,副作用を軽減する可能性を秘めています.
  • この分野は引き続き非常に重要であり,有望な薬剤候補が地平線にあります.